Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer Drugs. This report contains market size and forecasts of Platinum-based Anticancer Drugs in global, including the following market information:
Global Platinum-based Anticancer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Platinum-based Anticancer Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Platinum-based Anticancer Drugs companies in 2022 (%)
The global Platinum-based Anticancer Drugs market was valued at US$ 1586.5 million in 2022 and is projected to reach US$ 1823.6 million by 2029, at a CAGR of 2.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
We surveyed the Platinum-based Anticancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Platinum-based Anticancer Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum-based Anticancer Drugs Market Segment Percentages, by Type, 2022 (%)
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Global Platinum-based Anticancer Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum-based Anticancer Drugs Market Segment Percentages, by Application, 2022 (%)
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Global Platinum-based Anticancer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Platinum-based Anticancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platinum-based Anticancer Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Platinum-based Anticancer Drugs revenues share in global market, 2022 (%)
Key companies Platinum-based Anticancer Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Platinum-based Anticancer Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira(Pfizer)
Mylan
Taj Pharmaceuticals
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Luoxin
Lingnan Pharmacy
Hansoh Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Platinum-based Anticancer Drugs, market overview.
Chapter 2: Global Platinum-based Anticancer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Platinum-based Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Platinum-based Anticancer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Platinum-based Anticancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Platinum-based Anticancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Platinum-based Anticancer Drugs Overall Market Size
2.1 Global Platinum-based Anticancer Drugs Market Size: 2022 VS 2029
2.2 Global Platinum-based Anticancer Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Platinum-based Anticancer Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Platinum-based Anticancer Drugs Players in Global Market
3.2 Top Global Platinum-based Anticancer Drugs Companies Ranked by Revenue
3.3 Global Platinum-based Anticancer Drugs Revenue by Companies
3.4 Global Platinum-based Anticancer Drugs Sales by Companies
3.5 Global Platinum-based Anticancer Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Platinum-based Anticancer Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Platinum-based Anticancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Platinum-based Anticancer Drugs Players in Global Market
3.8.1 List of Global Tier 1 Platinum-based Anticancer Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Platinum-based Anticancer Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Platinum-based Anticancer Drugs Market Size Markets, 2022 & 2029
4.1.2 Cisplatin
4.1.3 Carboplatin
4.1.4 Oxaliplatin
4.1.5 Nedaplatin
4.1.6 Others
4.2 By Type - Global Platinum-based Anticancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Platinum-based Anticancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Platinum-based Anticancer Drugs Revenue, 2024-2029
4.2.3 By Type - Global Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Platinum-based Anticancer Drugs Sales & Forecasts
4.3.1 By Type - Global Platinum-based Anticancer Drugs Sales, 2018-2023
4.3.2 By Type - Global Platinum-based Anticancer Drugs Sales, 2024-2029
4.3.3 By Type - Global Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Platinum-based Anticancer Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Platinum-based Anticancer Drugs Market Size, 2022 & 2029
5.1.2 Testicular Cancer
5.1.3 Osteosarcoma
5.1.4 Breast Cancer
5.1.5 Esophageal Cancer
5.1.6 NSCLC
5.1.7 Other
5.2 By Application - Global Platinum-based Anticancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Platinum-based Anticancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Platinum-based Anticancer Drugs Revenue, 2024-2029
5.2.3 By Application - Global Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Platinum-based Anticancer Drugs Sales & Forecasts
5.3.1 By Application - Global Platinum-based Anticancer Drugs Sales, 2018-2023
5.3.2 By Application - Global Platinum-based Anticancer Drugs Sales, 2024-2029
5.3.3 By Application - Global Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Platinum-based Anticancer Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Platinum-based Anticancer Drugs Market Size, 2022 & 2029
6.2 By Region - Global Platinum-based Anticancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Platinum-based Anticancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Platinum-based Anticancer Drugs Revenue, 2024-2029
6.2.3 By Region - Global Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Platinum-based Anticancer Drugs Sales & Forecasts
6.3.1 By Region - Global Platinum-based Anticancer Drugs Sales, 2018-2023
6.3.2 By Region - Global Platinum-based Anticancer Drugs Sales, 2024-2029
6.3.3 By Region - Global Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Platinum-based Anticancer Drugs Revenue, 2018-2029
6.4.2 By Country - North America Platinum-based Anticancer Drugs Sales, 2018-2029
6.4.3 US Platinum-based Anticancer Drugs Market Size, 2018-2029
6.4.4 Canada Platinum-based Anticancer Drugs Market Size, 2018-2029
6.4.5 Mexico Platinum-based Anticancer Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Platinum-based Anticancer Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Platinum-based Anticancer Drugs Sales, 2018-2029
6.5.3 Germany Platinum-based Anticancer Drugs Market Size, 2018-2029
6.5.4 France Platinum-based Anticancer Drugs Market Size, 2018-2029
6.5.5 U.K. Platinum-based Anticancer Drugs Market Size, 2018-2029
6.5.6 Italy Platinum-based Anticancer Drugs Market Size, 2018-2029
6.5.7 Russia Platinum-based Anticancer Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Platinum-based Anticancer Drugs Market Size, 2018-2029
6.5.9 Benelux Platinum-based Anticancer Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Platinum-based Anticancer Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Platinum-based Anticancer Drugs Sales, 2018-2029
6.6.3 China Platinum-based Anticancer Drugs Market Size, 2018-2029
6.6.4 Japan Platinum-based Anticancer Drugs Market Size, 2018-2029
6.6.5 South Korea Platinum-based Anticancer Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Platinum-based Anticancer Drugs Market Size, 2018-2029
6.6.7 India Platinum-based Anticancer Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Platinum-based Anticancer Drugs Revenue, 2018-2029
6.7.2 By Country - South America Platinum-based Anticancer Drugs Sales, 2018-2029
6.7.3 Brazil Platinum-based Anticancer Drugs Market Size, 2018-2029
6.7.4 Argentina Platinum-based Anticancer Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Platinum-based Anticancer Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Platinum-based Anticancer Drugs Sales, 2018-2029
6.8.3 Turkey Platinum-based Anticancer Drugs Market Size, 2018-2029
6.8.4 Israel Platinum-based Anticancer Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Platinum-based Anticancer Drugs Market Size, 2018-2029
6.8.6 UAE Platinum-based Anticancer Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Company Summary
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Major Product Offerings
7.1.4 Sanofi-Aventis Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi-Aventis Key News & Latest Developments
7.2 Yakult honsha
7.2.1 Yakult honsha Company Summary
7.2.2 Yakult honsha Business Overview
7.2.3 Yakult honsha Platinum-based Anticancer Drugs Major Product Offerings
7.2.4 Yakult honsha Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Yakult honsha Key News & Latest Developments
7.3 Dr Reddy's laboratories
7.3.1 Dr Reddy's laboratories Company Summary
7.3.2 Dr Reddy's laboratories Business Overview
7.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Major Product Offerings
7.3.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Dr Reddy's laboratories Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Platinum-based Anticancer Drugs Major Product Offerings
7.5.4 Teva Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Major Product Offerings
7.6.4 Fresenius Kabi Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Fresenius Kabi Key News & Latest Developments
7.7 Hospira(Pfizer)
7.7.1 Hospira(Pfizer) Company Summary
7.7.2 Hospira(Pfizer) Business Overview
7.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Major Product Offerings
7.7.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Hospira(Pfizer) Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Platinum-based Anticancer Drugs Major Product Offerings
7.8.4 Mylan Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Company Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Major Product Offerings
7.9.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Taj Pharmaceuticals Key News & Latest Developments
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Company Summary
7.10.2 Jiangsu Hengrui Medicine Business Overview
7.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Major Product Offerings
7.10.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Jiangsu Hengrui Medicine Key News & Latest Developments
7.11 Nanjing Pharmaceutical Factory
7.11.1 Nanjing Pharmaceutical Factory Company Summary
7.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Business Overview
7.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Major Product Offerings
7.11.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Nanjing Pharmaceutical Factory Key News & Latest Developments
7.12 Jiangsu Aosaikang Pharmaceutical
7.12.1 Jiangsu Aosaikang Pharmaceutical Company Summary
7.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Business Overview
7.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Major Product Offerings
7.12.4 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Jiangsu Aosaikang Pharmaceutical Key News & Latest Developments
7.13 Qilu Pharmaceutical
7.13.1 Qilu Pharmaceutical Company Summary
7.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Business Overview
7.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Major Product Offerings
7.13.4 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Qilu Pharmaceutical Key News & Latest Developments
7.14 Hisun Pharmaceutical
7.14.1 Hisun Pharmaceutical Company Summary
7.14.2 Hisun Pharmaceutical Business Overview
7.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Major Product Offerings
7.14.4 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Hisun Pharmaceutical Key News & Latest Developments
7.15 Luoxin
7.15.1 Luoxin Company Summary
7.15.2 Luoxin Business Overview
7.15.3 Luoxin Platinum-based Anticancer Drugs Major Product Offerings
7.15.4 Luoxin Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Luoxin Key News & Latest Developments
7.16 Lingnan Pharmacy
7.16.1 Lingnan Pharmacy Company Summary
7.16.2 Lingnan Pharmacy Business Overview
7.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Major Product Offerings
7.16.4 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Lingnan Pharmacy Key News & Latest Developments
7.17 Hansoh Pharma
7.17.1 Hansoh Pharma Company Summary
7.17.2 Hansoh Pharma Business Overview
7.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Major Product Offerings
7.17.4 Hansoh Pharma Platinum-based Anticancer Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Hansoh Pharma Key News & Latest Developments
8 Global Platinum-based Anticancer Drugs Production Capacity, Analysis
8.1 Global Platinum-based Anticancer Drugs Production Capacity, 2018-2029
8.2 Platinum-based Anticancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Platinum-based Anticancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Platinum-based Anticancer Drugs Supply Chain Analysis
10.1 Platinum-based Anticancer Drugs Industry Value Chain
10.2 Platinum-based Anticancer Drugs Upstream Market
10.3 Platinum-based Anticancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Platinum-based Anticancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Platinum-based Anticancer Drugs in Global Market
Table 2. Top Platinum-based Anticancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Platinum-based Anticancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Platinum-based Anticancer Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Platinum-based Anticancer Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Platinum-based Anticancer Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Platinum-based Anticancer Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Platinum-based Anticancer Drugs Product Type
Table 9. List of Global Tier 1 Platinum-based Anticancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Platinum-based Anticancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Platinum-based Anticancer Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Platinum-based Anticancer Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Platinum-based Anticancer Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Platinum-based Anticancer Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Platinum-based Anticancer Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Platinum-based Anticancer Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Platinum-based Anticancer Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Platinum-based Anticancer Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Platinum-based Anticancer Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Platinum-based Anticancer Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Platinum-based Anticancer Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Platinum-based Anticancer Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Platinum-based Anticancer Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Platinum-based Anticancer Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Platinum-based Anticancer Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Platinum-based Anticancer Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Platinum-based Anticancer Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Platinum-based Anticancer Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Platinum-based Anticancer Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Platinum-based Anticancer Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Platinum-based Anticancer Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Platinum-based Anticancer Drugs Sales, (K Units), 2024-2029
Table 46. Sanofi-Aventis Company Summary
Table 47. Sanofi-Aventis Platinum-based Anticancer Drugs Product Offerings
Table 48. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi-Aventis Key News & Latest Developments
Table 50. Yakult honsha Company Summary
Table 51. Yakult honsha Platinum-based Anticancer Drugs Product Offerings
Table 52. Yakult honsha Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Yakult honsha Key News & Latest Developments
Table 54. Dr Reddy's laboratories Company Summary
Table 55. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offerings
Table 56. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Dr Reddy's laboratories Key News & Latest Developments
Table 58. Sun Pharmaceutical Company Summary
Table 59. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 60. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sun Pharmaceutical Key News & Latest Developments
Table 62. Teva Company Summary
Table 63. Teva Platinum-based Anticancer Drugs Product Offerings
Table 64. Teva Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Teva Key News & Latest Developments
Table 66. Fresenius Kabi Company Summary
Table 67. Fresenius Kabi Platinum-based Anticancer Drugs Product Offerings
Table 68. Fresenius Kabi Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Fresenius Kabi Key News & Latest Developments
Table 70. Hospira(Pfizer) Company Summary
Table 71. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offerings
Table 72. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Hospira(Pfizer) Key News & Latest Developments
Table 74. Mylan Company Summary
Table 75. Mylan Platinum-based Anticancer Drugs Product Offerings
Table 76. Mylan Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Mylan Key News & Latest Developments
Table 78. Taj Pharmaceuticals Company Summary
Table 79. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offerings
Table 80. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Taj Pharmaceuticals Key News & Latest Developments
Table 82. Jiangsu Hengrui Medicine Company Summary
Table 83. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offerings
Table 84. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 86. Nanjing Pharmaceutical Factory Company Summary
Table 87. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offerings
Table 88. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Nanjing Pharmaceutical Factory Key News & Latest Developments
Table 90. Jiangsu Aosaikang Pharmaceutical Company Summary
Table 91. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 92. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Jiangsu Aosaikang Pharmaceutical Key News & Latest Developments
Table 94. Qilu Pharmaceutical Company Summary
Table 95. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 96. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Qilu Pharmaceutical Key News & Latest Developments
Table 98. Hisun Pharmaceutical Company Summary
Table 99. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 100. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Hisun Pharmaceutical Key News & Latest Developments
Table 102. Luoxin Company Summary
Table 103. Luoxin Platinum-based Anticancer Drugs Product Offerings
Table 104. Luoxin Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Luoxin Key News & Latest Developments
Table 106. Lingnan Pharmacy Company Summary
Table 107. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offerings
Table 108. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Lingnan Pharmacy Key News & Latest Developments
Table 110. Hansoh Pharma Company Summary
Table 111. Hansoh Pharma Platinum-based Anticancer Drugs Product Offerings
Table 112. Hansoh Pharma Platinum-based Anticancer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Hansoh Pharma Key News & Latest Developments
Table 114. Platinum-based Anticancer Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 115. Global Platinum-based Anticancer Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Platinum-based Anticancer Drugs Production by Region, 2018-2023 (K Units)
Table 117. Global Platinum-based Anticancer Drugs Production by Region, 2024-2029 (K Units)
Table 118. Platinum-based Anticancer Drugs Market Opportunities & Trends in Global Market
Table 119. Platinum-based Anticancer Drugs Market Drivers in Global Market
Table 120. Platinum-based Anticancer Drugs Market Restraints in Global Market
Table 121. Platinum-based Anticancer Drugs Raw Materials
Table 122. Platinum-based Anticancer Drugs Raw Materials Suppliers in Global Market
Table 123. Typical Platinum-based Anticancer Drugs Downstream
Table 124. Platinum-based Anticancer Drugs Downstream Clients in Global Market
Table 125. Platinum-based Anticancer Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Platinum-based Anticancer Drugs Segment by Type in 2022
Figure 2. Platinum-based Anticancer Drugs Segment by Application in 2022
Figure 3. Global Platinum-based Anticancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Platinum-based Anticancer Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Platinum-based Anticancer Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Platinum-based Anticancer Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Platinum-based Anticancer Drugs Revenue in 2022
Figure 9. By Type - Global Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Platinum-based Anticancer Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Platinum-based Anticancer Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Platinum-based Anticancer Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 23. US Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 28. Germany Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 37. China Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Platinum-based Anticancer Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Platinum-based Anticancer Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Platinum-based Anticancer Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Platinum-based Anticancer Drugs by Region, 2022 VS 2029
Figure 54. Platinum-based Anticancer Drugs Industry Value Chain
Figure 55. Marketing Channels
